Member Login
Search

 

Bladder & Kidney Cancer Academy 

______
Co-Directors
  <p>Co-Directors Neal Shore, MD<br />Chief Medical Officer,<br />Surgery & Oncology,<br />GenesisCare<br />Tom Jayram, MD<br />Co-Director, Advanced<br />Therapeutics Center,<br />Urology Associates, PC </p>

(co-hosted with Specialty Networks)

TOOK PLACE AT THE 
Marriott Downtown, Philadelphia, PA
October 24-26, 2024

 

To see photos from the 2024 event, follow #BKCA24 on social media. 

 

About the Event

Receive an intensive education on the most recent breakthroughs & approvals for all stages of bladder & kidney cancer. Our expert faculty will present, discuss, and debate all available preventative, diagnostic, therapeutic, and management options for bladder & kidney cancer in a highly interactive format, via didactic lectures as well as case-based and panel discussions. The meeting will start with a networking reception on Thursday afternoon and end Saturday mid-morning.

            
To see photos from the most recent event click here. 

Why Attend
You represent the future of our specialty! Throughout this conference, attendees will be encouraged to interact in the engaging and stimulating discourse.  

Registration
Register Now! The 100 available registration slots have been allocated by role: 70 MDs and 30 residents. Registration closes Friday, September 13. If you have questions about attending, please contact Katie O'Donnell at [email protected].

Agenda
Agenda now available. Note, content is subject to change.    


Hotel and Travel: To learn more about hotel and travel accommodations and expense reimbursements, click here.

Social Media: Use the hashtag #BKCA24 to share your excitement for this meeting on social media! 

Partnership: Specialty Networks is the organizer of the Bladder & Kidney Cancer Academy in cooperation with LUGPA. If you are interested in sponsoring/exhibiting, click here.  

Bladder & Kidney Cancer Academy was created to ensure urology/oncology fellows, residents, and physicians receive optimal education on bladder and kidney cancer diagnosis and management, advanced monitoring and care options, novel pharmaceutical therapies, and surgical advancements.